Climb Bio CEO and president Aoife Brennan said: "Adding CLYM116 to our pipeline represents a pivotal moment for Climb Bio as we advance our ambition of becoming a leader in developing best-in ...

Synlogic's chief executive Aoife Brennan (pictured above) said the results suggest that SYNB1934 has the potential to be a "transformative treatment" for patients with PKU, given current estimates ...

“I am delighted to welcome Dr. Perrin Wilson to the Climb Bio management team,” said Aoife Brennan, President and CEO of Climb Bio. “Perrin brings extensive experience and a track record of ...